Director's Dealings

Cellular Goods PLC

12 January 2024

 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014, as retained as part of the law of England and Wales. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

12 January 2024

Cellular Goods PLC

("Cellular Goods" or "The Company")

Director's Dealings

Cellular Goods (LSE: CBX), a UK-based company pioneering the use of lab-based and biosynthetic production methods for wellness and sustainability solutions, announces that Michael Edwards (Executive Director of Cellular Goods) has purchased a total of 1,400,000 ordinary shares in the Company ("Ordinary Shares"), the details of which are set out in the notification below. Following this purchase, Michael Edwards holds a total of 9,400,000 Ordinary Shares, representing 1.56 per cent of the Company's issued share capital.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1.	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Michael Edwards
2.	Reason for the Notification
a)	Position/status	Executive Director
b)	Initial notification / Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Cellular Goods PLC
b)	LEI	213800IXPX4Z2MKX2U28
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the Financial instrument, type of instrument	Ordinary shares
	Identification Code	GB00BK964W87
b)	Nature of the transaction	Purchase of shares
c)	Price(s) and volume(s)	Price(s) Volume(s) 0.707 pence per Ordinary Share 1,400,000 Ordinary Shares
d)	Aggregated information: · Aggregated volume · Price	1,400,000 Ordinary Shares 0.707 pence per Ordinary Share
e)	Date of the transaction	11 January 2024
f)	Place of the Transaction	London Stock Exchange

For further information please contact:

Cellular Goods
Michael Edwards Director	via FSCF [phone]
First Sentinel Corporate Finance (FSCF)
Investor Relations Rebecca Noonan [e-mail] Media Relations Rebecca Noonan [e-mail] Corporate Broker & Advisor Brian Stockbridge	[phone] [phone] [phone]
Novum Securities
Corporate Broker Colin Rowbury Jon Belliss	[phone]

About Cellular Goods PLC:

Cellular Goods is pioneering the use of lab-based and biosynthetic production methods for wellness and sustainability solutions. The Company launched with a focus on efficacy led and science-backed products utilising biosynthetics, and now employs its expertise across two verticals: premium next-generation cannabinoid skincare products, and carbon sequestration-as-a-service through its wholly owned business division, King Tide Carbon, which utilises biosynthetic algae and seaweed to provide scalable carbon removal. The Company is incorporated in the UK and listed on the Main Market of the London Stock Exchange. For more information, visit www.cellular-goods.com.

 

END